Clinical Trials Browser

Observational × CTLA-4 Antigen × Clear all

NCT04659343 2025-03-05

TDM for Optimized Outcome in Patients With mRCC.

Kidney Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT02154490 2023-06-01

Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer

1,864 enrolled 12 charts

Recurrent Squamous Cell Lung Carcinoma